Citi Pharma Limited (PSX:CPHL)
Pakistan
· Delayed Price · Currency is PKR 78.24
+7.11 (10.00%)
At close: May 13, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 17.87 billion as of May 13, 2025. Its market cap has increased by 217.27% in one year.
Market Cap
17.87B
Enterprise Value
18.49B
Revenue
13.19B
Ranking
n/a
PE Ratio
21.74
Stock Price
78.24
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 17.87B, an increase of 150.19%. That is a compound annual growth rate of 26.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 17.87B | 14.87% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 104.17B |
| Abbott Laboratories (Pakistan) | 82.40B |
| AGP Limited | 44.62B |
| Highnoon Laboratories | 43.61B |
| The Searle Company | 34.90B |
| Shifa International Hospitals | 25.21B |
| Ferozsons Laboratories | 11.39B |
| Otsuka Pakistan | 2.26B |